EPISODE · Mar 6, 2026 · 26 MIN
M2M Pulse: 7 Trends CDMO You Can’t Ignore
from Molecule to Market: Inside the outsourcing space · host Raman Sehgal
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with 20+ CEO and C-suite leaders from the CDMO ecosystem, exploring the overlooked trends for 2026. Nick Fortin, CEO, Codis Ankit Gupta, CEO, InstaPill Eric Edwards, MD, PhD, CEO, Phlow USA Dirk T. Lange, CEO, Pyramid Pharma Services Kaan-Fabian Kekec, Partner, Simon-Kucher Healthcare and Life Sciences J.D. Mowery, President, CDMO Division, Bora Pharmaceuticals Matthew Bio, CSO, Cambrex and President, Snapdragon Chemistry Bill Vincent, Biotech Entrepreneur, CEO and Board Member Philip Macnabb, CEO, Curia Christiane Bardroff, COO Leader Jason Anderson, CEO, Ensera Mark B, Anonymous CEO (not to be quoted by name) Adam Siebert, Managing Director, L.E.K. Consulting Stephen Dilly, CEO, Sonoma Biotherapeutics Elisabeth Stampa, CEO, Medichem Jon Alberdi, CEO, Vivebiotech Derek Hennecke, Founder, Investor and Board Member Bruce Thompson, CTO, Kincell Bio Molecule to Market is also sponsored by Bora Pharmaceuticals, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
What this episode covers
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with 20+ CEO and C-suite leaders from the CDMO ecosystem, exploring the overlooked trends for 2026. Nick Fortin, CEO, Codis Ankit Gupta, CEO, InstaPill Eric Edwards, MD, PhD, CEO, Phlow USA Dirk T. Lange, CEO, Pyramid Pharma Services Kaan-Fabian Kekec, Partner, Simon-Kucher Healthcare and Life Sciences J.D. Mowery, President, CDMO Division, Bora Pharmaceuticals Matthew Bio, CSO, Cambrex and President, Snapdragon Chemistry Bill Vincent, Biotech Entrepreneur, CEO and Board Member Philip Macnabb, CEO, Curia Christiane Bardroff, COO Leader Jason Anderson, CEO, Ensera Mark B, Anonymous CEO (not to be quoted by name) Adam Siebert, Managing Director, L.E.K. Consulting Stephen Dilly, CEO, Sonoma Biotherapeutics Elisabeth Stampa, CEO, Medichem Jon Alberdi, CEO, Vivebiotech Derek Hennecke, Founder, Investor and Board Member Bruce Thompson, CTO, Kincell Bio Molecule to Market is also sponsored by Bora Pharmaceuticals, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
NOW PLAYING
M2M Pulse: 7 Trends CDMO You Can’t Ignore
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m